Regeneron Otarmeni Gene Therapy FDA Hearing Breakthrough
TARRYTOWN, N.Y., April 23, 2026 Regeneron Pharmaceuticals has achieved a landmark milestone as the U.S. Food and Drug Administration...
hearing loss
Advertisement
Envoy Medical Acclaim Implant Trial Hits Key Milestone
WHITE BEAR LAKE, Minn., April 22, 2026 Envoy Medical, Inc. announced a major milestone in its pivotal clinical trial...
Acclaim Cochlear Implant Trial Nears Full Enrollment
WHITE BEAR LAKE, MINNESOTA, UNITED STATES — February 17, 2026 Envoy Medical announced that enrollment in its pivotal clinical...
Sensorion Secures €60M to Advance Gene Therapies for Hearing Loss
MONTPELLIER, France | January 28, 2026 — Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, announced a...
Envoy Medical Hits Six-Month Milestone in Acclaim® Cochlear Trial
November 18, 2025 — Austin, Texas — Envoy Medical, Inc. announced it has successfully enrolled its first 10 patients...
Advertisement
